Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05590624 · ClinicalTrials.gov registry record · NA

Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer

A NA study of Prostate Cancer, sponsored by Case Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05590624 is a NA study of Prostate Cancer that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 30 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05590624, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the impact of Mediterranean-type diets on the metabolism of men with localized prostate cancer. The optimal diet for men with a suspected diagnosis of Prostate Cancer (PCa) is currently unknown. More specifically, the suggested benefits of low carbohydrate and low fat diets in PCa are not determined.

Conditions Studied

Interventions

  • OTHER Lower-Carbohydrate Med-t-Diet
  • OTHER Low-Fat Med-t-Diet

Study Locations (1)

Ohio

  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation - Cleveland

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-09-03
Est. Completion 2026-12
Phase NA

Sponsor

Case Comprehensive Cancer Center

407 total trials

What the Registry Record Tells You About NCT05590624

The ClinicalTrials.gov registry entry for NCT05590624 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (95% lower). The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Lower-Carbohydrate Med-t-Diet is the first listed.

NCT05590624 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05590624 about?

NCT05590624 is a clinical study titled "Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer". The purpose of this study is to examine the impact of Mediterranean-type diets on the metabolism of men with localized prostate cancer. The optimal diet for men with a suspected diagnosis of Prostate Cancer (PCa) is currently unknown. More specifically, the suggested benefits of low carbohydrate an...

What is the current status of trial NCT05590624?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-09-03. Estimated completion is 2026-12.

What conditions does trial NCT05590624 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT05590624?

The interventions under investigation include: Lower-Carbohydrate Med-t-Diet (OTHER), Low-Fat Med-t-Diet (OTHER).

Who is sponsoring clinical trial NCT05590624?

This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05590624 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.